A double recombinant herpes virus of turkeys for the protection of chickens against Newcastle, infectious laryngotracheitis and Marek’s diseases

References

• Ashraf, A. & Shah, M.S. (2014). Newcastle disease: present status and future challenges for developing countries. African Journal of Microbiology Research, 8, 411–416. doi: 10.5897/AJMR2013.6540
   Google Scholar
• Boyle, D.B. & Coupar, B.E. (1988). Construction of recombinant fowlpox viruses as vectors for poultry vaccines. Virus Research, 10, 343–356. doi: 10.1016/0168-1702(88)90075-5
   PubMed Web of Science ®Google Scholar
• Bwala, D.G., Fasina, F.O., Van Wyk, A. & Duncan, N.M. (2011). Effect of vaccination with lentogenic vaccine and challenge with virulent Newcastle disease virus (NDV) on egg production in commercial and SPF chickens. International Journal of Poultry Science, 10, 98–105. doi: 10.3923/ijps.2011.98.105
   Google Scholar
• Coppo, M.J.C., Hartley, C.A. & Devlin, J.M. (2013a). Immune responses to infectious laryngotracheitis virus. Developmental and Comparative Immunology, 41, 454–462. doi: 10.1016/j.dci.2013.03.022
   PubMed Web of Science ®Google Scholar
• Coppo, M.J.C., Noormohammadi, A.H., Browning, G.F. & Devlin, J.M. (2013b). Challenges and recent advancements in infectious laryngotracheitis vaccines. Avian Pathology, 42, 195–205. doi: 10.1080/03079457.2013.800634
   PubMed Web of Science ®Google Scholar
• Esaki, M., Noland, L., Eddins, T., Godboy, A., Saeki, S., Saitoh, S., Yasuda, A. & Dorsey, K.M. (2013). Safety and efficacy of a turkey herpes virus vector laryngotracheitis vaccine for chickens. Avian Diseases, 57, 192–198. doi: 10.1637/10383-092412-Reg.1
   PubMed Web of Science ®Google Scholar
• Gelb, Jr. J., Ladman, B.S., Lacata, M.J., Shapiro, M.H. & Campion, L.R. (2007). Evaluating viral interference between infectious bronchitis virus and Newcastle disease virus vaccine strains using quantitative reverse transcription-polymerase chain reaction. Avian Diseases, 51, 924–934. doi: 10.1637/7930-020807-REGR.1
   PubMed Web of Science ®Google Scholar
• Godoy, A., Esaki, M., Flegg, P., Rosenberger, J.K., Rosenberger, S., Dorsey, K.M. & Gardin, Y. (2011). Compatibility of vectored LT vaccines and Vectormune HVT NDV. Proceedings of the annual AAAP meeting, Saint Louis, July 16–19, (p. 23).
   Google Scholar
• Guy, J.S., Barnes, H.J. & Smith, L.G. (1991). Increased virulence of modified-live infectious laryngotracheitis vaccine virus following bird-to-bird passage. Avian Diseases, 35, 348–355. doi: 10.2307/1591188
   PubMed Web of Science ®Google Scholar
• Iqbal, M. (2012). Progress toward the development of polyvalent vaccination strategies against multiple viral infections in chickens using herpes virus of turkeys as vector. Bioengineered, 3, 222–226. doi: 10.4161/bioe.20476
   PubMed Web of Science ®Google Scholar
• Johnson, D.I., Vagnozzi, A., Dorea, F., Riblet, S.M., Mundt, A., Zavala, G. & Garcia, M. (2010). Protection against infectious larynogotracheitis by in ovo vaccination with commercially available viral vector recombinant vaccines. Avian Diseases, 54, 1251–1259. doi: 10.1637/9401-052310-Reg.1
   PubMed Web of Science ®Google Scholar
• Kapczynski, D.R., Alfonso, C.L. & Miller, P.J. (2013). Immune responses of poultry to Newcastle disease virus. Developmental and Comparative Immunology, 41, 447–453. doi: 10.1016/j.dci.2013.04.012
   PubMed Web of Science ®Google Scholar
• Kapczynski, D.R., Esaki, M., Dorsey, K.M., Jiang, H., Jackwood, M., Moraes, M. & Gardin, Y. (2015). Vaccine protection of chickens against antigenically diverse H5 highly pathogenic avian influenza isolates with a live HVT vector vaccine expressing the influenza hemagglutinin gene derived from a clade 2.2 avian influenza. Vaccine, 33, 1197–1205. doi: 10.1016/j.vaccine.2014.12.028
   PubMed Web of Science ®Google Scholar
• Kim, S.-H., Wanasen, N., Paldurai, A., Xiao, S., Collins, P.L. & Samal, S.K. (2013). Newcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccines. PLoS ONE, 8, e74022. doi: 10.1371/journal.pone.0074022
   PubMed Web of Science ®Google Scholar
• Kumar, S., Nayak, B., Collins, P.L. & Samal, S.K. (2011). Evaluation of the Newcastle disease virus F and HN proteins in protective immunity by using a recombinant avian paramyxovirus type 3 vector in chickens. Journal of Virology, 85, 6521–6534. doi: 10.1128/JVI.00367-11
   PubMed Web of Science ®Google Scholar
• Landman, W.J.M., Vervaet, C., Remon, J.P., Huyge, K. & van Eck, J.H.H. (2017). Primary Newcastle disease vaccination of broilers: comparison of the antibody seroresponse and adverse vaccinal reaction after eye–nose drop or coarse spray application, and implication of the results for a previously developed coarse dry powder vaccine. Avian Pathology, 46, 451–461. doi: 10.1080/03079457.2017.1307941
   PubMed Web of Science ®Google Scholar
• Le Gros, F.X., Dancer, A., Giacomini, C., Pizzoni, L., Bublot, M., Graziani, M. & Prandini, F. (2009). Field efficacy trial of a novel HVT-IBD vector vaccine for 1-day-old broilers. Vaccine, 27, 592–596. doi: 10.1016/j.vaccine.2008.10.094
   PubMed Web of Science ®Google Scholar
• Marangon, S. & Busani, L. (2006). The use of vaccination in poultry production. Scientific and Technical Review of the Office International des Epizooties (Paris), 26, 265–274. doi: 10.20506/rst.26.1.1742
   Web of Science ®Google Scholar
• Martinez-Torrecuadrada, J.L., Saubi, N., Pages-Mante, A., Caston, J.R. & Casal, J.I. (2003). Structure-dependent efficacy of infectious bursal disease virus (IBDV) recombinant vaccines. Vaccine, 21, 3342–3350. doi: 10.1016/S0264-410X(02)00804-6
   PubMed Web of Science ®Google Scholar
• Morgan, R.W., Gelb, J.C., Schreurs, S., Lutticken, D., Rosenberger, J.K. & Sondermeijer, J.P. (1992). Protection of chickens from Newcastle and Marek's diseases with a recombinant Herpes virus of turkeys vaccine expressing the Newcastle disease virus fusion protein. Avian Diseases, 36, 858–872. doi: 10.2307/1591544
   PubMed Web of Science ®Google Scholar
• Muller, H., Mundt, E., Eterraadossi, N. & & Islam, R. (2012). Current status of vaccines against infectious bursal disease. Avian Pathology, 41, 133–139. doi: 10.1080/03079457.2012.661403
   PubMed Web of Science ®Google Scholar
• Ou, S.C. & Giambrone, J.J. (2012). Infectious laryngotracheitis virus in chickens. World Journal of Virology, 1, 142–149. doi: 10.5501/wjv.v1.i5.142
   PubMedGoogle Scholar
• Palya, V., Kiss, I., Tatar-Kis, T., Mato, T., Felfoldi, B. & Yardin, Y. (2012). Advancement in vaccination against Newcastle disease: recombinant HVT NDV provides high clinical protection and reduces challenge virus shedding with the absence of vaccine reactions. Avian Diseases, 56, 282–287. doi: 10.1637/9935-091511-Reg.1
   PubMed Web of Science ®Google Scholar
• Paniago, M., Gardin, Y., Palya, V., Cazaban C. & Lozano, F. (2016). Assessment of the compatibility between the vector RHVT-F and RHVT-H5 vaccines in SPF and commercial chickens. 65th Western Poultry Disease Conference (pp.195–196). Vancouver, BC, Canada.
   Google Scholar
• Pradhan, N.S., Prince, P.R., Madhumathi, J., Roy, P., Narayanan, R.B. & Antony, U. (2012). Protective immune responses of recombinant VP2 subunit antigen of infectious bursal disease virus in chickens. Veterinary Immunology and Immunopathology, 148, 293–301. doi: 10.1016/j.vetimm.2012.06.019
   PubMed Web of Science ®Google Scholar
• Reddy, S.K., Sharma, J.M., Ahmad, J., Reddy, D.N., McMillan, J.K., Cook, S.M., Wild, M.A. & Schwartz, R.D. (1996). Protective efficacy of a recombinant herpesvirus of turkeys as an in ovo vaccine against Newcastle and Marek’s diseases in specific pathogen free chickens. Vaccine, 14, 469–477. doi: 10.1016/0264-410X(95)00242-S
   PubMed Web of Science ®Google Scholar
• Reed, L.J. & Muench, H. (1938). A simple method of estimating fifty percent endpoints. The American Journal of Hygiene, 27, 493–497.
   Google Scholar
• Rodriguez-Avila, A., Oldoni, I., Riblet, S.M. & Garcia, M. (2007). Replication and transmission of live-attenuated infectious laryngotracheitis virus (ILTV) vaccines. Avian Diseases, 51, 905–911. doi: 10.1637/8011-041907-REGR.1
   PubMed Web of Science ®Google Scholar
• Sharma, J.M. (1999). Introduction to poultry vaccines and immunity. Advances in Veterinary Medicine, 41, 481–494. doi: 10.1016/S0065-3519(99)80036-6
   PubMedGoogle Scholar
• Slacum, G., Hein, R. & Lynch, P. (2009). The compatibility of HVT recombinants with other Marek’s disease vaccines. 58th Western Poultry Disease Conference (p. 285), Sacramento, CA.
   Google Scholar
• Sondermeijer, P.J., Claessens, J.A., Jenniskens, P.E., Mockett, A.P., Thijssen, R.A., Willemse, M.J. & Morgan, R.W. (1993). Avian herpesvirus as a live viral vector for the expression of heterologous antigens. Vaccine, 11, 349–358. doi: 10.1016/0264-410X(93)90198-7
   PubMed Web of Science ®Google Scholar
• Vagnozzi, A., Zavala, G., Riblet, S.M., Mundt, A. & Garcia, M. (2012). Protection induced by commercially available live-attenuated and recombinant viral vector vaccines against infectious laryngotracheitis virus in broiler chickens. Avian Pathology, 41, 21–31. doi: 10.1080/03079457.2011.631983
   PubMed Web of Science ®Google Scholar
• Witter, R.L. & Hunt, H.D. (1994). Poultry vaccines of the future. Poultry Science, 73, 1087–1093. doi: 10.3382/ps.0731087
   PubMed Web of Science ®Google Scholar